Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors

Journal of Sichuan University (Medical Science)

Volumn 41, Issue 4, 2010, Pages 575-580

  Wang, Shuai ^a   Ma, Xiao Yan ^a   Xia, Yang ^a   Zhang, Li Hong ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Epithelial ovarian cancer; Mitotic index; Monoclonal antibody of cell proliferation associated nuclear antigen; Proliferating cell nuclear antigen

Indexed keywords

EID: 77955379571     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Morimoto R, Satoh F, Munakami O, et al. Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas, Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J,2008,55(1),49-55.
2. Lo Muzio LI., Farina A, Robini C et al. Survivin as Prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett,2005,225(1),27-33.
3. Mita S, Nakai A, Maeda S, et al. Prognostic significance of Ki67 antigen immunostaining (MIB-I monoclonal antibody) in ovarian cancer. J Nippon Med Sch,2004,71(6),384-391.
4. Baak JP, van Do PH, Kurver PH, et al. The values of morphometry to classic prognostic factors in breast cancer. Cancer, 1985,56(2),374-382.
5. William J, Saro T, Furumito H. The future of breast cancer, the role of prognostic factors. Breast Cancer Res Tr,2005,89 (1),17-26.
6. Ismailm A, Sallamf A, Sleima E, et al. The diagnostic and prognostic roles of P53, P21 and Ki67 in some malignant melanoma, FC13. 2. J Eur Acad Dermatol Venereol(Suppl), 2004,18(2),184-187.
7. Kaern J, Trope C, Aghmesheh M, et al. A study of prognostic parameters predicting long - term survival in stage QI epithelial ovarian cancer. Int J Gynecol Cancer, 2004,14(1), 60-66.
8. KorkoloPoulou P, VassiloPoulos I, Konstantinidou AE, et al. The combined evaluation of P27 and Ki67 expression provides independent information on overall survival of ovarian carcinomapatients. Gynecol Oncol,2002,85(3),4042- 4141.
9. Baekelandt M, Khouja H, Kristensen G, et al. The potential prognostic and predictive significance of cell cycle - related proteins Ki67, P16, P14 and P57 in advanced ovarian cancer. Int J Gynecol Cancer.2004,14(1),100-101.
10. Munstedt K, von Gorgi R, Franke FE. Correlation between MIBI-determined tumor grouth fraction and incidence of tumor recurrence in early orarlan carcinomas. Cancer invest, 2004, 22 (2),185-194.
11. Israels ED, Israels LG. The cell cycle. Stem Cells, 2001, 19 (3),88-91.
12. Jalava P, KuoPio T, Juntti-Patinen L, et al. YKI 67 immunohistochemistry, a valuable marker in prognostication but with a risk of misclassifcation, proliferation subgroups formed based on Ki67 immunoreactivity and standardizedmitotic index. Histopathology,2006,48(2),674-682.
13. Ribeiro-Silva A, Chang D, Bisson FW, et al. Clinicopathological and immunohistochemical features of a sebaceous carcinoma arising within a benign dermoid cyst of the ovary. Virchows Arch,2003,443(4),574-578.
14. Novichkov EV, Votintsev AA. Ovarian cancer prognosis and expression of receptors to sex hormones and proliferative activity of tumor cells. Arkh Patol,2006,68(2),10-13.
15. Beresford MJ, Wilson GD, Makris A, et al. Measuring proliferation in breast cancer, practicalities and applications. Breast Cancer Res,2006,8(2),16-27.